Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.

Saved in:
Bibliographic Details
Title: Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.
Authors: Hainsworth JD; Sarah Cannon Cancer Center, 250 25th Avenue North, Nashville, TN 37203, USA. jhainsworth@tnonc.com, Burris HA 3rd, Billings FT 3rd, Bradof JE, Baker M, Greco FA
Source: Cancer [Cancer] 2001 Nov 01; Vol. 92 (9), pp. 2391-8.
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Print ISSN: 0008-543X (Print) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0008-543X
DOI:10.1002/1097-0142(20011101)92:9<2391::aid-cncr1587>3.0.co;2-m